Cannabis Verano scoops US$12M mortgage loan for Nevada & Arizona facilities Both properties are being used for cultivation and processing Rowan DunneMarch 25, 2025
Cannabis Entourage Health gets shareholder approval to exit public markets Stock will be de-listed by Mar. 31 Rowan DunneMarch 24, 2025
Gold ‘Strike while the iron is hot’: gold’s bull run may only be a short-term thing Within 4 or 5 years the yellow metal will only be worth about US$1,820 per ounce, Morningstar has predicted Rowan DunneMarch 21, 2025
Psychedelics Intranasal delivery tech developer ‘Polyrizon’ plans to administer psychedelics The Israeli company has an unnamed new partner involved with unspecified psychedelic drugs Rowan DunneMarch 18, 2025
Psychedelics Mescaline drug developer Neural Therapeutics closes funding needed for CSE listing This company's primary focus is making an extract from San Pedro -- a psychedelic cactus Rowan DunneMarch 14, 2025
Psychedelics MindBio Therapeutics uses AI speech analysis to see if you’ve taken its LSD drug The biopharma operator's lead drug candidate, MB22001, was created for microdosing Rowan DunneJanuary 24, 2025
Medical and Pharmaceutical bioAffinity Technologies secures Australian patent for ‘CyPath Lung’ spit test It will be issued within 3 months provided that there are no opposition filings made by third parties Rowan DunneJanuary 22, 2025
Cyber Security Cybersecurity specialist BIO-key soars on major contract with Egypt’s largest bank BIO-key will provide the National Bank of Egypt with access to its PortalGuard identify management platform Rowan DunneJanuary 15, 2025
Science and Research IGM Biosciences slides by 66% on discontinued drug development and lay offs The biotech company has put the halt on 2 therapeutics used to treat arthritis, lupus and myasthenia gravis Rowan DunneJanuary 10, 2025
Medical and Pharmaceutical SILO Pharma flies high on impending patent for intranasal PTSD drug The stock rose by 146% in early morning trading on the Nasdaq Rowan DunneJanuary 8, 2025